Abstract
AbstractThe adenosine A2A antagonist, KF18446 was labelled in the aromatic O‐methyl position using [11C]iodomethane. [4‐O‐methyl‐11C]KF18446 and [4‐O‐methyl‐11C]KW‐6002, an adenosine A2A antagonist that we radiolabelled previously, were evaluated in rats. In brain, both [4‐O‐methyl‐11C]KW‐6002 and [4‐O‐methyl‐11C]KF18446 showed the highest uptake in striata and lowest in frontal cortex. For [4‐O‐methyl‐11C]KW‐6002 maximal striata: frontal cortex ratio was 1.7 from 60 to 120 min. For [4‐O‐methyl‐11C]KF18446 maximal striata: frontal cortex ratio was 2.4 from 30 to 90 min. The amount of unchanged [4‐O‐methyl‐11C]KW‐6002 was > 98 % in striata and cerebellum at 75 min post‐injection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Labelled Compounds and Radiopharmaceuticals
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
